Client News

Onyx Pharmaceuticals To Present At The 27th Annual JPMorgan Healthcare Conference
01/05/2009

Onyx Pharmaceuticals, Inc.

Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
12/31/2008

Nektar Therapeutics

Celera and Abbott Revise Strategic Alliance from Profit Sharing to Worldwide Distribution and Royalty Agreements
12/29/2008

Celera Group

Cytokinetics Retains Development and Commercialization Rights to Ispinesib and SB-743921
12/23/2008

Cytokinetics, Inc.

Onyx Pharmaceuticals Names Matthew K. Fust Executive Vice President And Chief Financial Officer
12/23/2008

Onyx Pharmaceuticals, Inc.